Implantable Cardioverter Defibrillators (ICD)

The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corp. S-ICD System (subcutaneous implantable defibrillator) for patients at risk of sudden cardiac arre...

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a treatment option that provides protection for patie...

ICDs, battery life, advances in implantable cardioverter defibrillators

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the introduction of quadripolar lead devices to improve dev...

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

Boston Scientific, S-ICD, long-term data, TV-ICD, trial
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corp. S-ICD System (...
Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD)...
Biotronik, ProMRI, AFFIRM, trial, ICD, MRI systems, EP Lab
Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published in Heart Rhythm, the official journal of the Heart Rhythm Society,...
Quadripolar lead, Medtronic, Attain, VivaQuad, CRT-D
There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient...
Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE
The Emblem Subcutaneous Implantable Defibrillator (S-ICD) system from Boston Scientific Corp. is a treatment option that provides
Ecolab Healthcare's PD220 patient drape is the first to market specifically for Boston Scientific’s subcutaneous implantable cardioverter-...
The CorMatrix Cardiovascular CorMatrix CanGaroo ECM Envelope is for use with cardiac implantable electronic devices (CIED’s) including...
Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable...

Articles

Boston Scientific, S-ICD, long-term data, TV-ICD, trial
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific Corp. S-ICD System (...
There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient...
EP lab, Implantable Cardioverter Defibrillators, Heart Failure
Boston Scientific Corporation announced the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD...
Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
3 days 16 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
4 weeks 3 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
10 weeks 3 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...